The Caregiver Pathway - An Intervention to Support Caregivers of Critically Ill Patients
1 other identifier
interventional
196
1 country
1
Brief Summary
The aim of the project is to test the efficacy of a systematic intervention for individual follow-up of caregivers at the intensive care unit during a 12 month randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2021
CompletedFirst Posted
Study publicly available on registry
April 9, 2021
CompletedStudy Start
First participant enrolled
April 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2024
CompletedMay 31, 2025
May 1, 2025
3.5 years
March 24, 2021
May 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Post traumatic stress
Post traumatic stress will be measured with the Impact of Event Scale-Revised (IES\_R). The total score for the IES\_R ranges from 0 to 88. A higher score represents more severe symptoms of post traumatic stress disorder.
Group differences at f-up month 3
Post traumatic stress
Post traumatic stress will be measured with the Impact of Event Scale-Revised (IES\_R). The total score for the IES\_R ranges from 0 to 88. A higher score represents more severe symptoms of post traumatic stress disorder.
Group differences at f-up month 6
Post traumatic stress
Post traumatic stress will be measured with the Impact of Event Scale-Revised (IES\_R). The total score for the IES\_R ranges from 0 to 88. A higher score represents more severe symptoms of post traumatic stress disorder.
Group differences at f-up month 12
Anxiety and Depression
Anxiety and Depression will be measured with the Hospital Anxiety and Depression Scale (HADS). HADS consists of 14 items, and two subscales with seven items respectively. Score range is 0-21 for each subcale. Scores: 0-7= Normal, 8-10= Borderline abnormal (borderline case), 11-21= abnormal (case).
Change from baseline to f-up month 3
Anxiety and Depression
Anxiety and Depression will be measured with the Hospital Anxiety and Depression Scale (HADS). HADS consists of 14 items, and two subscales with seven items respectively. Score range is 0-21 for each subcale. Scores: 0-7= Normal, 8-10= Borderline abnormal (borderline case), 11-21= abnormal (case).
Change from baseline to f-up month 6
Anxiety and Depression
Anxiety and Depression will be measured with the Hospital Anxiety and Depression Scale (HADS). HADS consists of 14 items, and two subscales with seven items respectively. Score range is 0-21 for each subcale. Scores: 0-7= Normal, 8-10= Borderline abnormal (borderline case), 11-21= abnormal (case).
Change from baseline to f-up month 12
Quality Adjusted Life Years (QUALYs)
Quality Adjusted Life Years (QUALYs), an economic evaluation of the quality and quantity of life lived, will be derived from the RAND-12 (Short form health survey, developed by the non profit RAND corporation). QUALY scores range from 1 (perfect health) to 0 (death).
Group differences at f-up month 12
Secondary Outcomes (12)
Health related quality of life
Change from baseline to f-up month 3
Health related quality of life
Change from baseline to f-up month 6
Health related quality of life
Change from baseline to f-up month 12
Hope
Change from baseline to f-up month 3
Hope
Change from baseline to f-up month 6
- +7 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALStructured follow up at the ICU * 1-3 days after admittance: Map caregivers' prioritized symptoms, needs and preferences with a digital assessment tool, followed by a meeting with a nurse to address these issues. * Every 1-2 weeks: Repeat assessment of symptoms and needs with the assessment tool followed by a meeting with a nurse. * At discharge: Structured conversation focusing on information and preparation for the transition to a regular ward or to another hospital including a card with information and support. * Bereavement: Individualized support based on caregiver expressed needs, preferences and previous mapping, including a card with information and support. * Follow up: Caregivers or bereaved will be contacted after 4-6 weeks, and will be offered a follow up conversation either on phone or at the unit.
Follow up as usual (Control)
NO INTERVENTIONFollow up as usual at the ICU
Interventions
Structured support of caregivers at the ICU provided by a trained group of 10-15 ICU nurses
Eligibility Criteria
You may qualify if:
- Caregivers of patients admitted to the intensive care unit that is expected to receive invasive mechanical ventilation for at least 48 hours
- Between 18 and 70 years old
- Able to understand and speak Norwegian
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- The Dam Foundationcollaborator
Study Sites (1)
Oslo University Hospital
Oslo, 0424, Norway
Related Publications (2)
Watland S, Solberg Nes L, Hanson E, Ekstedt M, Stenberg U, Borosund E. The Caregiver Pathway, a Model for the Systematic and Individualized Follow-up of Family Caregivers at Intensive Care Units: Development Study. JMIR Form Res. 2023 Apr 25;7:e46299. doi: 10.2196/46299.
PMID: 37097744BACKGROUNDWatland S, Solberg Nes L, Ekeberg O, Rostrup M, Hanson E, Ekstedt M, Stenberg U, Hagen M, Borosund E. The Caregiver Pathway Intervention Can Contribute to Reduced Post-Intensive Care Syndrome Among Family Caregivers of ICU Survivors: A Randomized Controlled Trial. Crit Care Med. 2025 Mar 1;53(3):e555-e566. doi: 10.1097/CCM.0000000000006546. Epub 2024 Dec 24.
PMID: 39718436RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Elin Børøsund, PhD
Oslo University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior researcher
Study Record Dates
First Submitted
March 24, 2021
First Posted
April 9, 2021
Study Start
April 22, 2021
Primary Completion
October 21, 2024
Study Completion
October 21, 2024
Last Updated
May 31, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share